Clinical Study
Long-Term Consequences of Hepatitis C Viral Clearance on the CD4 (+) T Cell Lymphocyte Course in HIV/HCV Coinfected Patients
Table 1
Basic characteristics.
| Variable | SVR ( = 26) | Non-SVR ( = 20) | value |
| Age, years | 49.5 (IQR 46–55) | 50.5 (IQR 47–55) | 0.62 | Male sex | 21 (84%) | 11 (55%) | 0.19 | Nadir CD4+, cells/ll | 266 (IQR 206.5–377.5) | 256 (IQR 200–413.5) | 0.84 | Baseline, T cells/ll CD4+ absolute count cell/mm3 | 501 (IQR 406–617) | 620.5 (IQR 446.5–701.5) | 0.17 | HCV genotype 1 | 20 (77%) | 17 (85%) | 0.71 | Significant fibrosis (F3-F4) (Scheuer) | 13 (50%) | 14 (70%) | 0.33 | African American race | 15 (56.5%) | 10 (50%) | 0.76 | Baseline HCV viral load IU/mL | 669,000 (IQR 195,707–1,816,655) | 500,000 (IQR 155,637.5–1,095,135) | 0.66 |
|
|